
    
      In this study, approximately from 40 centers 1000 patients will be recruited. All patients
      will be followed-up till the study end.

      All the laboratory results, treatment protocols and responses will be recorded and assessed
      with EORTC Multiple Myeloma Specific Quality of Life Multiple Myeloma Specific (MY-20) and
      EORTC Quality of Life-C30 questionnaires.
    
  